Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Aurinia Pharmaceuticals Inc. (AUPH)

6.59   0.16 (2.49%) 05-17 16:00
Open: 6.4 Pre. Close: 6.43
High: 6.64 Low: 6.395
Volume: 599,018 Market Cap: 610M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.641 - 6.664 6.664 - 6.685
Low: 6.324 - 6.354 6.354 - 6.381
Close: 6.543 - 6.584 6.584 - 6.622

Technical analysis

as of: 2019-05-17 4:26:50 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 7.76     One year: 9.06
Support: Support1: 6.24    Support2: 6.00
Resistance: Resistance1: 6.64    Resistance2: 7.76
Pivot: 6.24
Moving Average: MA(5): 6.29     MA(20): 6.25
MA(100): 6.52     MA(250): 6.01
MACD: MACD(12,26): -0.01     Signal(9): -0.06
Stochastic oscillator: %K(14,3): 88.67     %D(3): 62.09
RSI: RSI(14): 60.11
52-week: High: 7.85  Low: 5.06  Change(%): 8.7
Average Vol(K): 3-Month: 70497  10-Days: 46399

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AUPH has closed above the upper band by 11.2%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 47.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to AUPH's normal range. The bands have been in this narrow range for 30 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 14 May 2019 23:10:03 Z
Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss

Tue, 14 May 2019 18:51:45 Z
After-Hours Earnings Report for May 14, 2019 : A, DOX, NEWR, EGHT, AUPH, FSM, TCS, VCTR, OCX, PANL, REED, UQM

Thu, 02 May 2019 17:14:43 Z
Aurinia Pharmaceuticals (AUPH) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Wed, 10 Apr 2019 15:15:28 Z
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Wed, 20 Mar 2019 04:06:26 Z
Aurinia Pharmaceuticals Inc (AUPH) Q4 2018 Earnings Conference Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 91.65
Shares Float (M) 91.65
% Held by Insiders
% Held by Institutions 30.50
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.750
EPS Est. Current Year -1.010
EPS Est. Next Year -0.390
EPS Est. Next Quarter -0.110
Forward EPS -0.550
Book Value (p.s.) 4.900
PEG Ratio
Profit Margin
Operating Margin -12129.16
Return on Assets (ttm) -39.8
Return on Equity (ttm) -48.2
Qtrly Rev. Growth -3.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -51.61
Levered Free Cash Flow (M) -32.84

Stock Valuations

P/E -8.79
P/E Growth Ratio 0.02
P/BV 1.34
P/CF -11.70

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2013-10-23
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.